Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: upset (37), troubled (31), concerned (1000), worried (215), anxious (71)

Body modification

Description: Nearly twenty years ago, a court was faced with an agonising decision: whether the proposed separation of conjoined twins was lawful
Url: /HealthProfessionals/Clinical-law-updates/Body-modification.aspx

Articulating best interests

Description: We are all well aware that adults with capacity make their own treatment decisions. There is no call to determine the
Url: /HealthProfessionals/Clinical-law-updates/Articulating-best-interests.aspx

Deprivation in Essex

Description: Mr CP was a 91 year old man living alone. He had early dementia, but coped at home with assistance.
Url: /HealthProfessionals/Clinical-law-updates/DeprivationinEssex.aspx

Adult cancer care wig fitting service - patient information

Description: This factsheet provides information about the adult cancer care wig fitting service at University Hospital Southampton NHS Foundation Trust (UHS).
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Adult-cancer-care-wig-fitting-service-1532-PIL.pdf

Trastuzumab (21 day-Maintenance)

Description: Chemotherapy Protocol BREAST CANCER TRASTUZUMAB (21 day- Maintenance) Regimen • Breast Cancer – Trastuzumab (21 day-Maintenance) Indication • Adjuvant treatment of breast cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Trastuzumab-21-day-Maintenance.pdf

Trastuzumab (21 day-Load)

Description: Chemotherapy Protocol BREAST CANCER TRASTUZUMAB (21 day-Load) Regimen • Breast Cancer – Trastuzumab (21 day-Load) Indication • Adjuvant treatment of breast cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Trastuzumab-21-day-Load.pdf

Trastuzumab Main

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER TRASTUZUMAB (21 day-Maintenance) Regimen • GI (upper) – Trastuzumab (21 day-Maintenance) Indication • Trastuzumab, in combination with
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/TrastuzumabMainVer1.2.pdf

Ménière's disease - patient information

Description: This factsheet explains what Ménière's disease is, the symptoms to look out for and how it is treated.
Url: /Media/UHS-website-2019/Patientinformation/Audiology/Ménières-disease-2563-PIL.pdf

Diarrhoea - patient information

Description: Patient information factsheet Diarrhoea Diarrhoea is passing looser or more frequent stools than is normal for you. It affects most people
Url: /Media/UHS-website-2019/Patientinformation/Generalmedicine/Diarrhoea-1360-PIL.pdf

Afatinib Ver 1

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Regimen AFATINIB NSCLC - Afatinib Indication Treatment of locally advanced or metastatic non-small
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/AfatinibVer1.pdf

41 to 50 of 95

Previous … 3 4 5 6 7 … Next